Fact CheckerSign in

NCT07152899Completed

Innovative Treatments for Neurogenic Dysphagia

New Approaches for the Treatment of Post-stroke Dysphagia and Dysphagia in Parkinson's Disease

Source: ClinicalTrials.gov · Last updated 3 Sept 2025

Brief summary (registry, in English)

This study aims to evaluate different non-invasive and neuromuscular stimulation treatments for neurogenic dysphagia in post-stroke and Parkinson's disease patients. The study is divided into three sub-studies: 1. Unilateral, bihemispheric, or sham transcranial Direct Current Stimulation (tDCS) in post-stroke dysphagia (patients ≥2 weeks from onset). 2. Bihemispheric or sham tDCS in Parkinson's disease-related dysphagia. 3. Neuromuscular stimulation therapy in post-stroke and Parkinson's disease dysphagia.

Status (registry)
Completed
Study type
Interventional
Enrollment
110 (actual)
First submitted
26 Aug 2025
Start date
15 Jun 2021
Primary completion date
15 Jan 2025
Lead sponsor
IRCCS National Neurological Institute "C. Mondino" Foundation
NCT number
NCT07152899

What you commit to

  • Study type: Interventional
  • Participants enrolled: 110
  • From 15 Jun 2021 to the primary completion date, 15 Jan 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Cognitive impairment affecting compliance with treatment

Other

  • Severe dysphagia requiring Percutaneous Endoscopic Gastrostomy (PEG) feeding for more than 1 year
  • Non-neurogenic causes of dysphagia
  • Contraindications to tDCS or NMES

Who the study is looking for

  • Adults aged 18-85 years
  • Diagnosis of post-stroke or Parkinson's disease-related dysphagia
  • Dysphagia duration ≥ 2 weeks for post-stroke patients and ≥ 6 months for Parkinson's disease patients
  • Ability to undergo rehabilitation therapy
  • Written informed consent obtained

Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Translational Neurophysiology
Coordinator of this site? Confirm its status
PaviaItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.